When building news apps, good software practices don't go out the window; but something else becomes more important — the content and the story.
In a talking points memo, Emeritus, the country's largest assisted living company, seeks to highlight the company's compassion and deride any need for greater regulation out of Washington.
Army Secretary John McHugh confirms to members of Congress that commanders in Iraq and Afghanistan failed to keep required field records: “Steps are being taken to make sure this doesn’t happen again.”
Opponents of the death penalty have hit upon an effective tactic: Learn who is making the lethal drugs used in executions and publicly shame them. Now, death penalty states are fighting to make the names of the drugs a state secret.
Unsatisfied with answers so far, leaders of the House veterans’ panel ask defense Secretary Chuck Hagel to explain why Army units can’t find field records from Iraq and Afghanistan.
As part of our ongoing investigation into patient safety, ProPublica reporters Marshall Allen and Olga Pierce produced this interactive story in collaboration with PBS Frontline and Ocupop during a May 11-16 hackathon.
Frequently asked questions about our Prescriber Checkup news application.
The MinnPost's open source Legislature Project makes it easy for newsrooms and individuals to identify and keep track of bills. Welcome, New York edition.
In the world of abusive prosecutors – where evidence can be withheld or invented in the name of winning convictions and without fear of punishment – Ken Anderson stands out: Anderson, a Texas prosecutor who abused his authority to help send an innocent man to prison for decades, now faces 10 years behind bars for his misconduct.
We’ve reported that the FDA has allowed drugs to stay on the market despite the fact that the research underpinning their safety and efficacy was tainted by fraud. New information shows that even after the FDA had cited the lab for falsifying data, the agency issued at least one brand new approval to a drug tested there.
As the hunt for suspects in the Boston bombings continues, we’ve pulled together some of the best reporting so far and who to follow for breaking news.
This week ProPublica reported that the Food and Drug Administration found "egregious" research violations at a major laboratory but didn't pull any affected drugs from the market and, years later, hasn't finished its review. Turns out that wasn't an anomaly.
In 2010, the FDA uncovered violations it later called "egregious" and "pervasive" at a major pharmaceutical testing lab. But even though the agency no longer knew for sure that drugs tested at the lab were safe, it allowed them to remain on pharmacy shelves with no new testing — in some cases until now. And the FDA won’t name the drugs.
Generic medications are generally safe and effective, because the Food and Drug Administration requests tests to prove they're equivalent to the name-brand originals. But here's a case where something went wrong.
ProPublica was able to pinpoint five drugs whose approval rested, at least in part, upon data from a now defunct firm with "egregious" research violations
As tensions simmer over North Korea’s latest nuclear threats, we take a look at some of the best reading on Kim Jong Un, the prospects for a nuclear conflict and life in the DPRK.